Legislation
-
ACRI: One man’s vision for a borderless African cosmetic industry
Discover how Percy Sibanda’s ACRI is turning regulatory intelligence into a growth engine for Africa’s beauty industry—linking science, law, and market realities to cut risk, speed innovation, and enable cross‑border scale. Meet the chemist‑lawyer redefining compliance as competitive advantage.
-
Lenacapavir HIV prevention registration approved by SAHPRA
SAHPRA has approved Lenacapavir, an innovative HIV-1 prevention treatment that offers six-monthly injections for lasting protection. Discover how this breakthrough medicine could change HIV prevention for South Africans.
-
Quality medication goes beyond compliance
Concerns over sub-standard cancer medication in Africa are on the rise. Cipla Africa CEO Paul Miller shares why true quality in medicine means going beyond basic compliance—and why manufacturers must never cut corners to protect patient safety.
-
IQ/OQ certification: Ensure compliance with Labotec’s expertise
Stay audit-ready with Labotec’s IQ/OQ certification—trusted by South African pharma labs to meet strict compliance and validation standards. Discover how expert equipment qualification can protect your business and simplify regulatory approval.
-
The critical role of logistics in South Africa’s healthcare sector
Discover how innovative logistics are making life-saving healthcare deliveries possible across South Africa—even in regions with tough infrastructure challenges. Find out why efficient supply chains are essential for ensuring vital medicines and equipment reach those who need them most.
-
Schwan Cosmetics launches sustainable packaging solutions
Schwan Cosmetics sets a new standard in beauty with its EcoVadis Platinum Certification and the launch of FLX-TECHNOLOGY—an innovative, fully recyclable packaging solution. Discover how this breakthrough helps beauty brands meet 2030 EU sustainability targets with ease and style.
-
Eurolab’s court victory paves way for affordable cancer treatment in SA
Eurolab’s landmark court win means South Africans can now access Enzutix, a more affordable prostate cancer treatment. Discover how this case could change the future of medicine and patents in South Africa.
-
SAHPRA-WHO gear up to fight falsified medicines
Discover how SAHPRA and WHO are joining forces to protect South Africa from dangerous, fake medicines. Learn about their new strategies to boost safety, ensure quality, and keep our healthcare system strong—see what this means for your business and the future of public health.
-
Croda Beauty Actives transitions to PFAS-free peptides
Croda Beauty Actives is taking the lead by shifting to PFAS-free peptides, addressing growing safety concerns around these ‘forever chemicals’ in cosmetics. Discover how this move prioritises both sustainability and your well-being—read more about the industry’s new standards.
-
Laboratory compliance in the pharma and life sciences industries
Discover why GxP compliance is critical for biotech and pharma labs, and how trusted solutions from Labotec help meet strict regulatory standards. Learn about the key elements of laboratory compliance that support credibility, quality, and ongoing success in the industry.
-
Independent tests confirm safety of Benylin
Independent tests by SAHPRA confirm no harmful substances in recalled Benylin Paediatric Syrup batches. With strict quality checks and no reported issues, Kenvue stands by the safety of its products—read more on the latest findings and what it means for your peace of mind.
-
Systematic reforms required in SA’s manufacturing industry to address health and safety concerns
Deadly factory accidents have exposed urgent gaps in health and safety across South Africa’s manufacturing industry. Experts warn that without systematic reforms and stricter enforcement, more lives could be at risk—discover what needs to change to protect workers and ensure compliance.
